Pharmacological Inhibition of Epidermal Growth Factor Receptor Prevents Intracranial Aneurysm Rupture by Reducing Endoplasmic Reticulum Stress
Taichi Ishiguro(Barrow Neurological Institute), Tomoki Hashimoto(Barrow Neurological Institute), Daisuke Kudo(Barrow Neurological Institute), Jinglu Ai(Barrow Neurological Institute), Michael T. Lawton(Barrow Neurological Institute), Redi Rahmani(Barrow Neurological Institute), Hiroki Sato(Barrow Neurological Institute), Yushiro Take(Barrow Neurological Institute), Oscar Cisneros(Barrow Neurological Institute), Takuma Maeda(Barrow Neurological Institute), Kyle Polen(Barrow Neurological Institute), Hajime Furukawa(Barrow Neurological Institute), Hiroki Uchikawa(Barrow Neurological Institute), Jordan Morgan(Barrow Neurological Institute), Satoru Eguchi(University of South Florida)
Cited by 5
Related Papers
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
|Physiological Reviews|2018|1.1k
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.
|Journal of Clinical Investigation|1993|573
Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells
|Journal of Biological Chemistry|1998|566
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488